Bifidobacterium bifidum Rosell-71
What does the research say about Bifidobacterium bifidum Rosell-71?
4 health outcomes synthesisedResearch on Bifidobacterium bifidum Rosell-71 spans 4 health outcomes, with the strongest evidence for improving depressive symptoms based on 4 studies showing moderate beneficial effects. Studied populations include adults with psychiatric and cognitive disorders, though no specific dose or duration is consistently reported across trials.
Strongest evidence: The most robust finding is for improved depressive symptoms, supported by 4 studies (all systematic reviews or meta-analyses) with moderate evidence strength. All 4 studies reported beneficial effects, with 1 reaching statistical significance. Effect size was moderate across the board.
Mixed or weaker evidence: Three outcomes—improved cognitive function, reduced depression symptoms, and improved mental health—have lower or very low evidence strength. For cognitive function, effect sizes varied from small to large across 3 studies, and only 1 meta-analysis reached statistical significance (SMD -0.90 in depression patients). The reduced depression symptoms outcome had 3 studies all showing moderate benefits, but 2 of which were statistically significant (one 2025 meta-analysis reported SMD -0.55). Improved mental health had 3 studies all showing small, non-significant effects.
Effective dose patterns: No consistent dose or duration was reported across outcomes, limiting cross-cutting dose insights. Effective doses remain unspecified in the research syntheses.
Population insights: The strongest evidence comes from adults, particularly those with psychiatric or cognitive disorders. For cognitive function, studied populations included patients with depressive symptoms, Alzheimer's disease, and general healthy adults. Mental health research focused on adult humans.
Notable caveats: All outcomes share common caveats: small evidence bases (3-4 studies each) making conclusions preliminary, potential publication bias favoring positive results, and many studies not reaching statistical significance, suggesting true effects may be smaller than observed. Doses and study durations were often unreported.
Frequently asked
What is Bifidobacterium bifidum Rosell-71 good for according to research?
Research shows Bifidobacterium bifidum Rosell-71 has been studied primarily for mental health outcomes. The strongest evidence is for improved depressive symptoms (4 studies, moderate evidence strength), with all studies reporting beneficial effects. Weaker evidence suggests potential benefits for cognitive function, reduced depression symptoms, and general mental health, but findings are preliminary and often not statistically significant.What dose of Bifidobacterium bifidum Rosell-71 is typically used in studies?
No specific dose or duration is consistently reported across the studies for any of the four outcomes. This lack of dosing data is a major limitation of the current research, making it impossible to identify an effective dose range from the available syntheses.Who benefits most from Bifidobacterium bifidum Rosell-71?
The strongest evidence is in adults with psychiatric and cognitive disorders, particularly for depressive symptoms. Cognitive function studies included patients with depressive symptoms, Alzheimer's disease, and general healthy adults. However, small study numbers and lack of consistent population data limit firm conclusions.Are there caveats or limitations in the research on Bifidobacterium bifidum Rosell-71?
Significant caveats include small evidence bases (3-4 studies per outcome), potential publication bias favoring positive results, and many studies not reaching statistical significance. This suggests true effects may be smaller than observed. Doses and study durations were often unreported, and conclusions should be considered preliminary.Does Bifidobacterium bifidum Rosell-71 help with cognitive function?
Three studies on cognitive function all reported beneficial effects, but evidence strength is low. Effect sizes ranged from small to large, with only 1 meta-analysis finding a statistically significant large effect (in depression patients, SMD -0.90). The other two reviews did not reach significance, and high heterogeneity (I²=82%) was noted.Does Bifidobacterium bifidum Rosell-71 affect mental health outcomes?
Three studies reported small beneficial effects on mental health, but none reached statistical significance and evidence strength is very low. All data come from general probiotic reviews rather than direct interventional trials on this specific strain, making these results the weakest among the four outcomes.
- Moderate evidenceImproved Depressive Symptoms
- Low evidenceReduced Depression Symptoms
- Low evidenceImproved Cognitive Function
- Very low evidenceImproved Mental Health
- Improved Gastrointestinal Symptoms
- Improved Gut Microbiota Balance
- Improved Liver Function
- Reduced Total Infections
- Reduced Neuroinflammation
- Reduced Anxiety